Commonwealth Equity Services’s Biolase BIOL Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOL
Commonwealth Equity Services's BIOL Position: Q3 2023 in Review
Commonwealth Equity Services sold out of Biolase (BIOL) in Q3 2023, closing a stake of 757 shares — an estimated $5K sold.
Commonwealth Equity Services first reported a position in BIOL in Q4 2015 and held it in 13 quarters. The position peaked at $35K in Q1 2022. 12 funds tracked by Wall St. Rank hold BIOL as of Q3 2023.
- Commonwealth Equity Services reported no remaining Biolase position as of Q3 2023 after selling out during the quarter.
- Commonwealth Equity Services sold 757 Biolase shares in Q3 2023, an estimated $5K.
- Commonwealth Equity Services first reported a position in Biolase in Q4 2015 and held it in 13 quarters.
- Commonwealth Equity Services's Biolase position peaked at $35K in Q1 2022.
- 12 funds tracked by Wall St. Rank held Biolase as of Q3 2023.
Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.